Magnosco GmbH
A non-invasive method utilizing laser technology for the early detection of malignant melanoma is offered, enabling doctors to identify abnormal skin cells based on changes in melanin fluorescence. The approach aids in timely diagnosis, enhancing patient prognosis by distinguishing normal from malignant cells.
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...
Insights
Loading Insights...
Loading Insight content to display...
Loading Insights...
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...
Funding
Workforce
Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A